Keyphrases
Tumor
100%
Radiation Dosimetry
100%
Lutetium-177 (177Lu)
100%
DOTATOC
100%
Peptide Receptor Radionuclide Therapy
100%
Mass Dose
83%
Single-photon Emission Computed Tomography (SPECT)
50%
Therapeutic Index
50%
Kidney Dose
50%
Peptide Mass
50%
Kidney
33%
Three-dimensional (3D)
33%
Absorbed Dose
33%
Lung
16%
Treatment Response
16%
Whole-body
16%
Liver
16%
SPECT-CT
16%
Initial Treatment
16%
2-cycles
16%
Lymph Node
16%
CT Images
16%
Attenuation Correction
16%
Radiation Absorbed Dose
16%
Computer Tomography Image
16%
Individualized Dosing
16%
Neuroendocrine Tumor
16%
Volume Reduction
16%
Dose-ranging
16%
Metastasizing
16%
CT Data
16%
Lesion Volume
16%
Peptide Concentration
16%
Target Lesion
16%
Biologically Effective Dose
16%
DOTATATE
16%
Mid-thigh
16%
Dose Index
16%
Normalized Mean
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Receptor
100%
Dosimetry
100%
Radioisotope
100%
Lutetium 177
100%
Therapeutic Window
50%
Liver Injury
16%
Neuroendocrine Tumor
16%
Immunology and Microbiology
Peptides
100%
Peptide Receptor
100%
Computer Assisted Tomography
18%
Lymph Node
9%
Single Photon Emission Computed Tomography
9%
Lesion Volume
9%
Single Photon Emission Computed Tomography-Computed Tomography
9%